Literature DB >> 21210291

Predictors of radiographic severity and functional disability in Turkish patients with ankylosing spondylitis.

Döndü Usküdar Cansu1, Cüneyt Calışır, Ulaş Savaş Yavaş, Timuçin Kaşifoğlu, Cengiz Korkmaz.   

Abstract

The objective of this study is to investigate the association between clinical and laboratory prognostic factors, radiographic severity, and functional limitations in Turkish patients with ankylosing spondylitis (AS). One hundred and two patients with AS were included in this study (66 male patients, 65%). All the necessary information regarding predictor variables, including clinical features, social status, and treatment regimens, were recorded diligently. Their spinal mobility was measured, and then, their disease activities were evaluated by using the Bath Ankylosing Spondylitis Disease Activity Index. Radiological damage (Bath Ankylosing Spondylitis Radiology Index, BASRI) and functional disability (Bath Ankylosing Spondylitis Functional Index, BASFI) were used to evaluate the outcome measures of AS. The male to female ratio was 1.8. Average age at symptom onset was 23.9 ± 28.24 years (6-54 years), and average disease duration was 16.15 ± 10.62 years. Occiput-to-wall distance, hand-to-floor distance, and the modified Schober's test results were worse in males. Hip involvement was more common in male patients, and all radiological measurements were worse in male patients than in the female ones. Disease duration, male sex, and renal stone occurrence were associated with higher radiological score. Erythrocyte sedimentation rate and the disease activity score were associated with high BASFI scores. Higher CRP levels and hip involvement were both associated with high BASRI and BASFI scores. Radiological hip involvement was determined to be an inauspicious predictor for AS (p < 0.0001). We determined a strong association of hip involvement, increased CRP levels, and renal stone history with severe radiographic damage. Hip involvement, disease duration, ESR, CRP levels, and lower socioeconomic status were all associated with a higher BASFI score.

Entities:  

Mesh:

Year:  2011        PMID: 21210291     DOI: 10.1007/s10067-010-1665-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  21 in total

Review 1.  Comparison of the Dougados Functional Index and the Bath Ankylosing Spondylitis Functional Index. A literature review.

Authors:  J Ruof; G Stucki
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

2.  Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression.

Authors:  S Brophy; A Calin
Journal:  J Rheumatol       Date:  2001-10       Impact factor: 4.666

3.  A review of 100 patients with ankylosing spondylitis with particular reference to socio-economic effects.

Authors:  B P Wordsworth; A G Mowat
Journal:  Br J Rheumatol       Date:  1986-05

4.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

5.  The natural disease course of ankylosing spondylitis.

Authors:  S Carette; D Graham; H Little; J Rubenstein; P Rosen
Journal:  Arthritis Rheum       Date:  1983-02

6.  HLA--B27 homozygosity in ankylosing spondylitis: relationship to risk and severity.

Authors:  M A Khan; I Kushner; W E Braun; A A Zachary; A G Steinberg
Journal:  Tissue Antigens       Date:  1978-05

7.  A case-control study of juvenile- and adult-onset ankylosing spondylitis.

Authors:  S H Marks; M Barnett; A Calin
Journal:  J Rheumatol       Date:  1982 Sep-Oct       Impact factor: 4.666

8.  Increased frequency of ultrasonographic findings suggestive of renal stones in patients with ankylosing spondylitis.

Authors:  C Korkmaz; A Ozcan; N Akçar
Journal:  Clin Exp Rheumatol       Date:  2005 May-Jun       Impact factor: 4.473

Review 9.  Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort.

Authors:  Wonuk Lee; John D Reveille; John C Davis; Thomas J Learch; Michael M Ward; Michael H Weisman
Journal:  Ann Rheum Dis       Date:  2006-11-24       Impact factor: 19.103

10.  Predictors of longterm outcome in ankylosing spondylitis.

Authors:  Michele F Doran; Sinead Brophy; Kirsten MacKay; Gordon Taylor; Andrei Calin
Journal:  J Rheumatol       Date:  2003-02       Impact factor: 4.666

View more
  21 in total

1.  Risk factors for urolithiasis in patients with ankylosing spondylitis: a prospective case-control study.

Authors:  Emel Gönüllü; N Şule Yaşar Bilge; Döndü U Cansu; Müge Bekmez; Ahmet Musmul; Nevbahar Akçar; Timuçin Kaşifoğlu; Cengiz Korkmaz
Journal:  Urolithiasis       Date:  2016-08-19       Impact factor: 3.436

Review 2.  Urolithiasis as an extraarticular manifestation of ankylosing spondylitis.

Authors:  Cengiz Korkmaz; Döndü Üsküdar Cansu; John A Sayer
Journal:  Rheumatol Int       Date:  2017-08-18       Impact factor: 2.631

3.  Urolithiasis in ankylosing spondylitis: Correlation with Bath ankylosing spondylitis disease activity index (BASDAI), Bath ankylosing spondylitis functional index (BASFI) and Bath ankylosing spondylitis metrology index (BASMI).

Authors:  Sasan Fallahi; Ahmad Reza Jamshidi; Farhad Gharibdoost; Mahdi I Mahmoud; Pedram Paragomi; Mohammad Hossein Nicknam; Elham Farhadi; Mostafa Qorbani
Journal:  Caspian J Intern Med       Date:  2012

Review 4.  Cardiovascular risk in the rheumatic disease patient undergoing orthopedic surgery.

Authors:  Susan M Goodman; C Ronald Mackenzie
Journal:  Curr Rheumatol Rep       Date:  2013-09       Impact factor: 4.592

5.  Clinical patterns and characteristics of ankylosing spondylitis in China.

Authors:  Qiaoxia Qian; Xia Xu; Hongjun He; Hengdong Ji; Hui Zhang; Yue Ding; Sheng-Ming Dai; Yaohong Zou; Qi Zhu; Chengde Yang; Shuang Ye; Lindi Jiang; Jian-Ping Tang; Qiang Tong; Dongyi He; Dongbao Zhao; Yuan Li; Yanyun Ma; Jingru Zhou; Ziyu Yuan; Juan Zhang; Li Jin; Xiaodong Zhou; John D Reveille; Hejian Zou; Jiucun Wang
Journal:  Clin Rheumatol       Date:  2017-05-27       Impact factor: 2.980

6.  The clinical usefulness of ESR, CRP, and disease duration in ankylosing spondylitis: the product of these acute-phase reactants and disease duration is associated with patient's poor physical mobility.

Authors:  Chun-Hsiung Chen; Hung-An Chen; Hsien-Tzung Liao; Chin-Hsiu Liu; Chang-Youh Tsai; Chung-Tei Chou
Journal:  Rheumatol Int       Date:  2015-02-24       Impact factor: 2.631

7.  Functional limitation and associated factors in outpatients with ankylosing spondylitis in Southwest China.

Authors:  Yuqing Song; Chen Wang; Hong Chen
Journal:  Clin Rheumatol       Date:  2017-02-06       Impact factor: 2.980

Review 8.  Sexual dimorphism in the prevalence, manifestation and outcomes of axial spondyloarthritis.

Authors:  Rachael Stovall; Irene E van der Horst-Bruinsma; Shao-Hsien Liu; Tamara Rusman; Lianne S Gensler
Journal:  Nat Rev Rheumatol       Date:  2022-09-15       Impact factor: 32.286

9.  Mean platelet volume, red cell distribution width, platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients with ankylosing spondylitis and their relationships with high-frequency hearing thresholds.

Authors:  Nazim Bozan; Mahmut Alpaycı; Mehmet Aslan; Hakan Cankaya; Ahmet Faruk Kıroglu; Mahfuz Turan; Abdurrahman Ayral; Emre Senkoy; Server Ilter
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-31       Impact factor: 2.503

10.  Both baseline clinical factors and genetic polymorphisms influence the development of severe functional status in ankylosing spondylitis.

Authors:  Ruxandra Schiotis; Nerea Bartolomé; Alejandra Sánchez; Magdalena Szczypiorska; Jesús Sanz; Eduardo Cuende; Eduardo Collantes Estevez; Antonio Martínez; Diego Tejedor; Marta Artieda; Anca Buzoianu; Juan Mulero
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.